Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Plasma myeloperoxidase-conjugated DNA level predicts outcomes and organ dysfunction in patients with septic shock

Fig. 1

MPO-DNA and cf-DNA levels. Plasma levels of myeloperoxidase (MPO)-DNA and cell-free DNA (cf-DNA) in patients with septic shock and control subjects. MPO-DNA (a) and cf-DNA (b) levels on day 1, day 3, and day 7 after the diagnosis of septic shock are compared with those in healthy volunteers (HV). Data are shown as box plots with median values (lines inside the boxes), 25th and 75th centiles (borders of the boxes), and whiskers indicating the range. Data beyond the whiskers are plotted as outliers (small circles). The number of patients is shown in parentheses. *p < 0.05 vs. day 1; ††p < 0.01 vs. healthy volunteers

Back to article page